Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy
NCT05187026 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2022-01-26
Summary
This is an observational study where prostate cancer related PROMs (EPIC-26) is collected using two different methods (by paper questionnaires and electronically) and patient experience and preference is asked.
Conditions
Interventions
- OTHER
-
electronic PROMs questionnaire
Patients are asked to complete EPIC-26 questionnaire in paper and electronically
Sponsors & Collaborators
-
Helsinki University Central Hospital
lead OTHER
Principal Investigators
-
Antti S Rannikko, MD, PhD · Helsinki University Central Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-09
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- Finland
Study Locations
More Related Trials
-
Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion
NCT01913717 ·Status: UNKNOWN ·Phase: NA
-
Prostate Delineation: High Quality Volume CT
NCT01878773 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
NCT03160794 ·Status: RECRUITING ·Phase: NA
-
PSMA-PET Registry for Recurrent Prostate Cancer
NCT03718260 ·Status: RECRUITING ·Phase: NA
-
Salvage Prostatectomy After Radiotherapy
NCT00791115 ·Status: COMPLETED ·Phase: NA
-
Assessment of New Molecular Imaging Strategies for Prostate Cancer
NCT02813226 ·Status: COMPLETED ·Phase: NA
-
MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy
NCT00775866 ·Status: COMPLETED ·Phase: NA
-
Adaptive MR-guided SBRT for Localized Prostate Cancer
NCT04571762 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
NCT05761366 ·Status: RECRUITING ·Phase: PHASE2
-
Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk
NCT03417336 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer
NCT02107287 ·Status: COMPLETED ·Phase: NA
-
PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.
NCT03340272 ·Status: UNKNOWN
-
MRI-guided Brachytherapy and Salvage SBRT Program
NCT07132671 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Low Dose Hemi-body Radiation For Recurrent Prostate Cancer
NCT03196778 ·Status: COMPLETED ·Phase: NA
-
Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate
NCT03034187 ·Status: RECRUITING
-
Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery
NCT01766492 ·Status: UNKNOWN
-
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
NCT05361902 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer
NCT02668718 ·Status: UNKNOWN ·Phase: PHASE3
-
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
NCT05106699 ·Status: RECRUITING ·Phase: NA
-
Tumor TARGET Prostate Cancer
NCT01802242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
NCT05141760 ·Status: COMPLETED ·Phase: PHASE2
-
24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer
NCT05936736 ·Status: RECRUITING ·Phase: NA
-
Study Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided Biopsy
NCT02450266 ·Status: UNKNOWN ·Phase: NA
-
HRQOL in Prostate Cancer Patients Treated With Radiotherapy
NCT05645237 ·Status: ACTIVE_NOT_RECRUITING
-
PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
NCT04642027 ·Status: RECRUITING ·Phase: PHASE3